Skip to content
Wednesday, November 11, 2026
Play Digital Magazine

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Package Over Data Apprehensions

Medical funding illustration
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has turned down a major US health deal valued at $367m (272 million pounds) spanning five years because of Washington's insistence on confidential information.

The decision came to light after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".

A government spokesman later explained that the United States was demanding access to genetic material for scientific study and profit while refused to share the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged continued dialogue to secure a agreement agreeable to both sides so the country's vital HIV programme can proceed.

Wider Background

Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar deal with the US following concerns were raised about the safety of citizens' medical information.

Since resuming office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

USAID had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.

According to reports, 16 African countries have so far agreed to these new agreements, representing over $18.3bn in committed funds.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to share its genetic material and health information for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.

"Put simply, our nation would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our population if a new pandemic emerge."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks already established via the global organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future pandemics.

"This system is designed to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

These objections regarding the US deal "should not be misconstrued as opposition to America," he added.

"We are open to further discussions with our US partners on how future collaboration could be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Response

Medical experts said it understood the official position, but urged that talks should continue since a large portion of the nation's Aids initiatives relied on foreign aid.

"Where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and negotiated safeguards," the group commented.

This impasse highlights the ongoing debate between receiving vital international aid and protecting a country's data in an increasingly data-driven world.

About the author

Kathryn Fisher

A tech journalist and digital culture enthusiast with a passion for uncovering emerging trends in gaming and interactive media.

Play Digital Magazine

Type to search articles.